Literature DB >> 15762337

The growth of the nasal septum in the 6-9 week period of foetal development--Warfarin embryopathy offers a new insight into prenatal facial development.

A M Howe1, J K Hawkins, W S Webster.   

Abstract

BACKGROUND: The aim of this study was to de the role of the nasal septum in embryonic facial development.
METHODS: Nasal septal growth and facial development were examined in sagittally-sectioned 6-9 week human foetuses and compared to previously published data for later prenatal periods. To complement this data a cephalometric study of a child with untreated warfarin embryopathy was undertaken since a previous study in rats had shown warfarin exposure interferes with septal growth.
RESULTS: The results showed that prenatal septal growth was maximal during the 6-9 week period and resulted in the establishment of a facial profile that was maintained until birth. This critical of growth corresponds to the period of warfarin exposure of the human foetus that results warfarin embryopathy. The cephalometric examination of a child with untreated warfarin embryopathy showed a combination of short anterior cranial base and a short maxilla had contributed to a significant retrusion of the maxilla suggestive of failure of the midface to devel the 6-9 week period.
CONCLUSION: These findings would support the hypothesis that the nasal septum plays an active role in embryonic midfacial development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15762337     DOI: 10.1111/j.1834-7819.2004.tb00069.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  5 in total

1.  Warfarin embryopathy: fetal manifestations.

Authors:  Helen Wainwright; Peter Beighton
Journal:  Virchows Arch       Date:  2010-10-05       Impact factor: 4.064

2.  Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis.

Authors:  Satoru Hayano; Yoshihiro Komatsu; Haichun Pan; Yuji Mishina
Journal:  Development       Date:  2015-03-05       Impact factor: 6.868

3.  Matrix Gla protein deficiency impairs nasal septum growth, causing midface hypoplasia.

Authors:  Juliana Marulanda; Hazem Eimar; Marc D McKee; Michelle Berkvens; Valentin Nelea; Hassem Roman; Teresa Borrás; Faleh Tamimi; Mathieu Ferron; Monzur Murshed
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

4.  Maternal Folic Acid Deficiency Is Associated to Developing Nasal and Palate Malformations in Mice.

Authors:  Estela Maldonado; Elena Martínez-Sanz; Teresa Partearroyo; Gregorio Varela-Moreiras; Juliana Pérez-Miguelsanz
Journal:  Nutrients       Date:  2021-01-16       Impact factor: 5.717

5.  Septal chondrocyte hypertrophy contributes to midface deformity in a mouse model of Apert syndrome.

Authors:  Woo-Jin Kim; Hyun-Mo Ryoo; Bong-Soo Kim; Hye-Rim Shin; Hyun-Jung Kim; Heein Yoon; Young-Dan Cho; Kang-Young Choi; Je-Yong Choi
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.